Clinical Trial Update: Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers. [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 trial assessing melatonin for preventing COVID-19 in healthcare workers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Instituto de Investigación Hospital Universitario La Paz | Conditions: Covid19, SARS-CoV 2 | Phase 2, Phase 3 | Status: COMPLETED